Home Measurement of arginine derivatives in pediatric patients with chronic kidney disease using high-performance liquid chromatography-tandem mass spectrometry
Article
Licensed
Unlicensed Requires Authentication

Measurement of arginine derivatives in pediatric patients with chronic kidney disease using high-performance liquid chromatography-tandem mass spectrometry

  • Sihe Wang , Faye B. Vicente , Alan Miller , Ellen R. Brooks , Heather E. Price and Frederick A. Smith
Published/Copyright: October 10, 2007
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 45 Issue 10

Abstract

Background: The arginine derivatives asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) interfere with endothelial nitric oxide synthesis. Plasma ADMA and SDMA have been shown to be risk factors for cardiovascular disease and/or kidney function deterioration in a variety of patient populations.

Methods: We developed a method to quantitatively measure arginine, ADMA, and SDMA using HPLC-tandem mass spectrometry. 13C6-L-Arginine was used as the internal standard, while the derivatives were separated on a silica column in less than 14 min. Plasma levels of ADMA, SDMA, and arginine were measured in children with stage II or III chronic kidney disease (CKD) and age- and gender-matched siblings.

Results: The chromatography exhibited no observable ion suppression in the patient specimens tested. There was no apparent carryover for any of the analytes. The assay was linear over 0.32–2.29, 0.23–4.43, and 1.00–303.89 μmol/L for ADMA, SDMA, and arginine, respectively. Plasma ADMA, SDMA, and arginine (mean±SD) were 1.10±0.35, 2.06±1.11, and 57.93±22.10 μmol/L for children with CKD, and 0.78±0.16, 0.71±0.23, and 65.29±21.30 μmol/L for the healthy siblings.

Conclusions: The method exhibited no observable ion suppression in the patient specimens tested and has an acceptably short analytical cycle time. Children with CKD had higher levels of ADMA and SDMA than the healthy siblings.

Clin Chem Lab Med 2007;45:1305–12.


Corresponding author: Sihe Wang, Department of Clinical Pathology, The Cleveland Clinic, 9500 Euclid Avenue L11, Cleveland, OH 44195, USA Phone: +1-216-4452634, Fax: +1-216-4444414,

Received: 2007-3-8
Accepted: 2007-5-24
Published Online: 2007-10-10
Published in Print: 2007-10-01

©2007 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Atrial natriuretic peptide and related peptides
  2. The −374A allele of the receptor for advanced glycation end products (RAGE) gene promoter is a protective factor against cardiovascular lesions in type 2 diabetes mellitus patients
  3. Biochemical properties of endogenous presenilin 1 and presenilin 2 in cultured human B-lymphocytes
  4. CD36 polymorphism and its relationship with body mass index and coronary artery disease in a Korean population
  5. Preservation of RNA for functional analysis of separated alleles in yeast: comparison of snap-frozen and RNALater® solid tissue storage methods
  6. Mother-child double incompatibility at vWA and D5S818 loci in paternity testing
  7. Matrix metalloprotease-2 and -9 concentration and activity in serum and culture medium samples: a methodological reappraisal
  8. Are changes in blood-ethanol concentration during storage analytically significant? Importance of method imprecision
  9. Measurement of arginine derivatives in pediatric patients with chronic kidney disease using high-performance liquid chromatography-tandem mass spectrometry
  10. The soluble transferrin receptor reflects tumor load in chronic lymphocytic leukemia
  11. Calculated low-density lipoprotein cholesterol remains a viable and important test for screening and targeting therapy
  12. Angiotensin-converting enzyme (ACE) I/D corrected serum ACE activity and severity assessment of community-acquired pneumonia
  13. Differentiating transudative from exudative pleural effusion: should we measure effusion cholesterol dehydrogenase?
  14. Association of classical and related inflammatory markers with high-sensitivity C-reactive protein in healthy individuals: results from the Stanislas cohort
  15. Cytokines and growth factors in mostly atherosclerotic patients on hemodialysis determined by biochip array technology
  16. Use of a solid-phase extraction with radioimmunoassay to identify the proportional bias of clinical B-type natriuretic peptide immunoassay: the impact of plasma matrix and antibody multispecificity
  17. High plasma levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) and interleukin-8 (IL-8) characterize patients prone to ventricular fibrillation complicating myocardial infarction
  18. Methylprednisolone, cortisol and the cell-mediated immune response in children after ventricular septal defect repair
  19. Standardization of γ-glutamyltransferase assays by intermethod calibration. Effect on determining common reference limits
  20. The effect of endurance exercise-induced lactacidosis on biochemical markers of bone turnover
  21. Serum biobank certification and the establishment of quality controls for biological fluids: examples of serum biomarker stability after temperature variation
  22. Diagnostic usefulness of a third-generation anti-cyclic citrulline antibody test in patients with recent-onset polyarthritis
  23. Clinical significance of the laboratory determination of low serum copper in adults
  24. National survey on critical values reporting in a cohort of Italian laboratories
  25. Influence of haemodialysis on the NT-proBNP plasma concentration
  26. C–588T polymorphism of the human glutamate-cysteine ligase modifier subunit gene is not associated with the risk and extent of ischemic heart disease in a German cohort
  27. Has homocysteine shrunk?
Downloaded on 10.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2007.277/html
Scroll to top button